glp 1 blindness study The popularity of GLP-1 agonists (Ozempic, Wegovy, Semaglutide) is unmatched, but we are just beginning to see the catastrophic eye complications. I recently saw a healthy woman in her early 40s with A recent study analyzing data

Introduction You have likely seen the vibrant bottles and sleek packets claiming to be the ultimate shortcut to cellular wellness

September 15, 2025 Update: The number of claims in the GLP-1 gastroparesis litigation continues to rise, with more than 2,400 cases pending in federal court before U.S

Eight [percent] to 20% is what were seeing in [patients without cancer], and in our breast cancer population, we saw a more modest 5%

some countries restrict the import of unlabeled injectable solutions regardless of therapeutic purpose

has been an invited speaker at Biogen MA Inc., Danone, Eisai, WebMD Neurology (Medscape), Novo Nordisk, Springer Healthcare and European Brain Council